Koya

Info

Contact Andy Doraiswamy
Title CEO

Description

At Koya, we are developing the next-generation wearable therapeutic platform which offers compression anytime, anywhere. Compression therapy has wide-ranging applications from treating debilitating diseases such as chronic edema, Chronic Venous Insufficiency (CVI), Congestive Heart Failure (CHF), lymphedema, Deep-Vein Thrombosis (DVT), and post-surgical recovery.  Today, the compression and edema market is estimated to be >$4B and growing at 7% CAGR. Existing solutions such as stockings, manual drainage, and Pneumatic Compression Devices (PCDs) are archaic and ineffective. PCDs are bulky, noisy, tethered, and difficult-to-use, yet they remain the standard-of-care for both home-health and hospital care. Our founding team has deep experience in successfully bringing value-based health technologies to market. Koya’s platform is based on advanced materials that allows electro-active compression to be weaved into clothing, making it a truly wearable therapeutic. This platform allows patient-specific patterned compression that is tailored, quiet, portable, and easy-to-wear. We are focused in developing the technology for treating edema with a sensor-based closed-loop system that can address the patient’s chronic needs. The device is IoT-enabled to remotely monitor and enable compliance. Our lean and hyper-efficient operating plan allows us to solve a large and growing unmet need.